MDxHealth (MDXH) SEC Filings & 10K Form

$2.87
+0.05 (+1.77%)
(As of 01:19 PM ET)

Recent MDxHealth SEC Filings

DateFilerForm TypeView
05/06/2024
7:00 AM
MDxHealth (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/01/2024
3:03 PM
MDxHealth (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/01/2024
7:54 AM
MDxHealth (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2024
4:20 PM
MDxHealth (Filer)
Form 424B5
03/06/2024
4:04 PM
MDxHealth (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2024
2:38 PM
Bleichroeder LP (Filed by)
MDxHealth (Subject)
Form SC 13G/A
01/08/2024
3:39 PM
MDxHealth (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/24/2023
12:24 PM
MDxHealth (Subject)
Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
11/24/2023
12:25 PM
MDxHealth (Filer)
Form 8-A12B/A
11/15/2023
3:01 PM
MDxHealth (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2023
4:06 PM
MDxHealth (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/08/2023
3:23 PM
MDxHealth (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/06/2023
7:00 AM
MDxHealth (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/23/2023
4:09 PM
MDxHealth (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2023
3:50 PM
MDxHealth (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/10/2023
5:12 AM
MDxHealth (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/03/2023
7:46 AM
MDxHealth (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/05/2023
4:27 PM
MDxHealth (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/03/2023
3:00 PM
MDxHealth (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/06/2023
4:29 PM
MDxHealth (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:MDXH) was last updated on 5/16/2024 by MarketBeat.com Staff

From Our Partners